Return to search

Hochdosis-Chemotherapie gefolgt von einer myeloablativen Hochdosis-Radioimmuntherapie (HD-RAIT) mit Iod-131-Rituximab und peripherer Stammzelltransplantation (SCTx) bei primär refraktären und rezidivierten Non-Hodgkin-Lymphomen / High Dose Chemotherapy followed by a myeloablative radioimmunotherapy and stem cell transplantation with I-131-anti CD20 Antibody in relapsed and primary refractory B- Cell lymphoma

No description available.

1. http://hdl.handle.net/11858/00-1735-0000-0006-B187-0
2. urn:nbn:de:gbv:7-webdoc-2803-4
3. webdoc-2803
4. 656436115

Identifer	oai:union.ndltd.org:uni-goettingen.de/oai:ediss.uni-goettingen.de:11858/00-1735-0000-0006-B187-0
Date	21 February 2011
Creators	Mehari, Symon
Contributors	Meller, Johannes Prof. Dr.
Source Sets	Georg-August-Universität Göttingen
Language	German
Detected Language	English
Type	doctoralThesis
Format	application/pdf
Rights	http://creativecommons.org/licenses/by-nc-nd/3.0/